These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 466929)
1. Kinetics and metabolism of carbamazepine during combined antiepileptic drug therapy. Eichelbaum M; Köthe KW; Hoffman F; von Unruh GE Clin Pharmacol Ther; 1979 Sep; 26(3):366-71. PubMed ID: 466929 [TBL] [Abstract][Full Text] [Related]
2. The mechanism of the carbamazepine-valproate interaction in humans. Bernus I; Dickinson RG; Hooper WD; Eadie MJ Br J Clin Pharmacol; 1997 Jul; 44(1):21-7. PubMed ID: 9241092 [TBL] [Abstract][Full Text] [Related]
3. Carbamazepine 10, 11 epoxide concentrations in epileptics on carbamazepine alone and in combination with other anticonvulsants. Brodie MJ; Forrest G; Rapeport WG Br J Clin Pharmacol; 1983 Dec; 16(6):747-9. PubMed ID: 6661364 [TBL] [Abstract][Full Text] [Related]
4. Carbamazepine and carbamazepine-10,11-epoxide serum concentrations in epileptic children. Furlanut M; Montanari G; Bonin P; Casara GL J Pediatr; 1985 Mar; 106(3):491-5. PubMed ID: 3973787 [TBL] [Abstract][Full Text] [Related]
5. Carbamazepine metabolism in man. Induction and pharmacogenetic aspects. Eichelbaum M; Tomson T; Tybring G; Bertilsson L Clin Pharmacokinet; 1985; 10(1):80-90. PubMed ID: 3971637 [TBL] [Abstract][Full Text] [Related]
6. Metabolism of carbamazepine and co-administered anticonvulsants during pregnancy. Bernus I; Hooper WD; Dickinson RG; Eadie MJ Epilepsy Res; 1995 May; 21(1):65-75. PubMed ID: 7641678 [TBL] [Abstract][Full Text] [Related]
11. Use of stable labelled carbamazepine to study its kinetics during chronic carbamazepine treatment. Eichelbaum M; Köthe KW; Hoffmann F; von Unruh GE Eur J Clin Pharmacol; 1982; 23(3):241-4. PubMed ID: 6816617 [TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacokinetics of anticonvulsants. Hvidberg EF; Dam M Clin Pharmacokinet; 1976; 1(3):161-88. PubMed ID: 797496 [TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of carbamazepine and its epoxide and diol metabolites in epileptic patients: the influence of dose and comedication. Rambeck B; May T; Juergens U Ther Drug Monit; 1987 Sep; 9(3):298-303. PubMed ID: 3672573 [TBL] [Abstract][Full Text] [Related]
14. Combined administration of carbamazepine and phenobarbital: effect on anticonvulsant activity and neurotoxicity. Bourgeois BF; Wad N Epilepsia; 1988; 29(4):482-7. PubMed ID: 3391152 [TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacokinetics of carbamazepine. Bertilsson L Clin Pharmacokinet; 1978; 3(2):128-43. PubMed ID: 346287 [TBL] [Abstract][Full Text] [Related]
17. Role of carbamazepine in reducing polypharmacy in epilepsy. Maheshwari MC; Padmini R Acta Neurol Scand; 1981 Jul; 64(1):22-8. PubMed ID: 7324872 [TBL] [Abstract][Full Text] [Related]
18. Serum protein binding of antiepileptic drugs in Sri Lankans. Karunanayake EH; Joice PD; Peiris JB; Meijer JW; Meinardi H Ceylon Med J; 1990 Mar; 35(1):25-8. PubMed ID: 2361227 [TBL] [Abstract][Full Text] [Related]
19. Problem of spurious correlation in the evaluation of steady-state carbamazepine levels using metabolite data. van Belle G; Friel PN Ther Drug Monit; 1986; 8(2):177-83. PubMed ID: 3726931 [TBL] [Abstract][Full Text] [Related]
20. Carbamazepine-10,11-diol steady-state serum levels and renal excretion during carbamazepine therapy in adults and children. Bourgeois BF; Wad N Ther Drug Monit; 1984; 6(3):259-65. PubMed ID: 6506133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]